DHFR inhibitors (University of Connecticut/Spero)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameDHFR inhibitors (University of Connecticut/Spero)
Drug Alias NameDHFR inhibitors (Promiliad Biopharma)dihydrofolate reductase inhibitors (Promiliad Biopharma)
ClassificationNatural product/ExtractSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionDihydrofolate reductase inhibitors
TargetsDihydrofolate reductase
Therapy Area/IndicationsStreptococcus Pyogenes InfectionsNeoplasmsCryptosporidiosis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPromiliad Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPromiliad Biopharma IncUniversity Of ConnecticutSpero Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsStreptococcus Pyogenes InfectionsNeoplasmsCryptosporidiosis +[5] 

Other Information

ATC CodeN/A
Related LinksN/A